Hi! Good to see ya. An ER doctor in Chicago told the New York Times last week that he sees “Croc-specific injuries” once a ...
Healthcare investors spooked by recent headlines on cuts to Medicare Advantage and a new Justice Department probe of UnitedHealth Group Inc.'s billing practices are worrying about the wrong thing.
The “Big Three” PBMs are kicking their suit up to the 8th Circuit, and in the meantime once again asking a Missouri district ...
Digital health is in dire need of consolidation. But startups looking to sell may have to settle for lower prices from their ...
UnitedHealth Group’s share price has dropped by 11% in the past week, largely due to a Department of Justice investigation ...
Recent health news highlights disruptions in HIV and malaria supply chains due to a U.S. aid freeze, FDA's approval of a new ...
Health sector stocks fluctuate amid DOJ probe into UnitedHealth (UNH), Gilead upgrade for HIV treatments, and Moderna's focus on non-COVID approvals.
This is part three of a 13-part series about companies whose shares have amassed 100,000% returns for investors and the path ...
The Justice Department is probing diagnoses and practices that triggered extra payments to UnitedHealth’s Medicare Advantage ...
The U.S. aid freeze disrupts supply chains for critical HIV and malaria products, while the FDA approves Mirum Pharma's new ...
New York Gov. Kathy Hochul announced she would not remove New York City Mayor Eric Adams from office over federal corruption ...
Hunter Smith offers a restaurant analogy in trying to illustrate the severe financial squeeze that pharmacy benefit managers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results